Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts

被引：0
|
作者：
Jelas, I [1 ]
de Bortoli, T. [2 ]
Benary, M. [2 ]
Horak, P. [3 ]
Lamping, M. [2 ]
Schaefer, R. [2 ]
Klauschen, F. [2 ]
Tinhofer-Keilholz, I [2 ]
Leyvraz, S. [2 ]
Keller, U. [2 ]
Stenzinger, A.
Froehling, S. [3 ]
Stintzing, S. [1 ,4 ]
Kurzrock, R. [5 ]
Keilholz, U. [2 ]
Rieke, D. [2 ]
机构：
[1] Charite Univ Med Berlin, Klin Hamatol Onkol & Tumorimmunol, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] NCT Heidelberg, Heidelberg, Germany
[4] Univ Klinikum Heidelberg, Heidelberg, Germany
[5] Worldwide Innovat Network WIN Assoc WIN Consortiu, Villejuif, France
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V563
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [1] Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts.
    Rieke, Damian Tobias
    De Bortoli, Till
    Benary, Manuela
    Horak, Peter
    Lamping, Mario
    Stintzing, Sebastian
    Tinhofer, Ingeborg
    Leyvraz, Serge
    Schaefer, Reinhold
    Klauschen, Frederick
    Keller, Ulrich
    Stenzinger, Albrecht
    Froehling, Stefan
    Kurzrock, Razelle
    Jelas, Ivan
    Keilholz, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for Convergence
    Passaro, Antonio
    Stenzinger, Albrecht
    Peters, Solange
    CANCER CELL, 2020, 38 (05) : 624 - 625
  • [3] Pan-cancer landscape of clonal tumor mutational burden (cTMB)
    Parikh, A. R.
    Murugesan, K.
    Hopkins, J. F.
    Arshad, Z.
    Jin, D. X.
    Klempner, S. J.
    Fabrizio, D. A.
    Frampton, G. M.
    He, J.
    Montesion, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S582 - S583
  • [4] Analytic validation of a pan-cancer tumor mutational burden assay
    Nesselbush, Monica
    Jones, Sian
    Keefer, Laurel
    Sengamalay, Naomi
    Velculescu, Victor
    Diaz, Luis
    Sausen, Mark
    Angiuoli, Samuel
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [5] The combination of hyper-amplification and tumor mutational burden as a pan-cancer biomarker in patients treated with tislelizumab.
    Deva, Sanjeev
    Millward, Michael
    Friedlander, Michael
    Gan, Hui K.
    Hovarth, Lisa G.
    Lee, Jong-Seok
    Hill, Andrew
    Sandhu, Shahneen
    Liang, Liang
    Shi, Jingwen
    Zhang, Yun
    Shi, Yang
    Ma, Xiaopeng
    Wu, Xikun
    Shen, Zhirong
    Desai, Jayesh
    CANCER RESEARCH, 2022, 82 (12)
  • [6] Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
    Papillon-Cavanagh, Simon
    Hopkins, Julia F.
    Ramkissoon, Shakti H.
    Albacker, Lee A.
    Walsh, Alice M.
    COMMUNICATIONS MEDICINE, 2021, 1 (01):
  • [7] Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
    Wu, Hao-Xiang
    Wang, Zi-Xian
    Zhao, Qi
    Chen, Dong-Liang
    He, Ming-Ming
    Yang, Lu-Ping
    Wang, Ying-Nan
    Jin, Ying
    Ren, Chao
    Luo, Hui-Yan
    Wang, Zhi-Qiang
    Wang, Feng
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [8] Pan-cancer analysis of the effect of biopsy site on tumor mutational burden observations
    Simon Papillon-Cavanagh
    Julia F. Hopkins
    Shakti H. Ramkissoon
    Lee A. Albacker
    Alice M. Walsh
    Communications Medicine, 1
  • [9] Tumour mutational burden and survival with molecularly matched therapy
    de Bortoli, Till
    Benary, Manuela
    Horak, Peter
    Lamping, Mario
    Stintzing, Sebastian
    Tinhofer, Ingeborg
    Leyvraz, Serge
    Schaefer, Reinhold
    Klauschen, Frederick
    Keller, Ulrich
    Stenzinger, Albrecht
    Froehling, Stefan
    Kurzrock, Razelle
    Keilholz, Ulrich
    Rieke, Damian T.
    Jelas, Ivan
    EUROPEAN JOURNAL OF CANCER, 2023, 190
  • [10] Evaluating Tumour Mutational Burden as a Key Biomarker in Personalized Cancer Immunotherapy: A Pan-Cancer Systematic Review
    Zgura, Anca
    Chipuc, Stefania
    Bacalbasa, Nicolae
    Haineala, Bogdan
    Rodica, Anghel
    Sebastian, Valcea
    CANCERS, 2025, 17 (03)
12345